Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. (NPPNY) Stock Competitors & Peer Comparison
See (NPPNY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NPPNY | $6.66 | +0.00% | 1.8B | 9.65 | $0.69 | +2.66% |
| MKGAF | $155.43 | +2.70% | 67.6B | 22.92 | $6.78 | +1.66% |
| MKKGY | $29.76 | -0.27% | 65B | 22.14 | $1.35 | +1.73% |
| IPSEY | $46.94 | -3.73% | 62.1B | 30.28 | $1.55 | +0.85% |
| TKPHF | $32.10 | -1.53% | 50.7B | 42.80 | $0.75 | +4.06% |
| HLNCF | $4.60 | -3.77% | 40.9B | 18.46 | $0.25 | +2.07% |
| SDZNY | $82.76 | +0.88% | 35.8B | 39.61 | $2.09 | +1.23% |
| TEVJF | $30.19 | +0.00% | 35.2B | 24.95 | $1.21 | N/A |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
NPPNY vs MKGAF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, MKGAF has a market cap of 67.6B. Regarding current trading prices, NPPNY is priced at $6.66, while MKGAF trades at $155.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas MKGAF's P/E ratio is 22.92. In terms of profitability, NPPNY's ROE is +0.11%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, NPPNY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MKGAF's competition here
NPPNY vs MKKGY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, MKKGY has a market cap of 65B. Regarding current trading prices, NPPNY is priced at $6.66, while MKKGY trades at $29.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas MKKGY's P/E ratio is 22.14. In terms of profitability, NPPNY's ROE is +0.11%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, NPPNY is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check MKKGY's competition here
NPPNY vs IPSEY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, IPSEY has a market cap of 62.1B. Regarding current trading prices, NPPNY is priced at $6.66, while IPSEY trades at $46.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas IPSEY's P/E ratio is 30.28. In terms of profitability, NPPNY's ROE is +0.11%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, NPPNY is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check IPSEY's competition here
NPPNY vs TKPHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TKPHF has a market cap of 50.7B. Regarding current trading prices, NPPNY is priced at $6.66, while TKPHF trades at $32.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TKPHF's P/E ratio is 42.80. In terms of profitability, NPPNY's ROE is +0.11%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, NPPNY is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check TKPHF's competition here
NPPNY vs HLNCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HLNCF has a market cap of 40.9B. Regarding current trading prices, NPPNY is priced at $6.66, while HLNCF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HLNCF's P/E ratio is 18.46. In terms of profitability, NPPNY's ROE is +0.11%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, NPPNY is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HLNCF's competition here
NPPNY vs SDZNY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SDZNY has a market cap of 35.8B. Regarding current trading prices, NPPNY is priced at $6.66, while SDZNY trades at $82.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SDZNY's P/E ratio is 39.61. In terms of profitability, NPPNY's ROE is +0.11%, compared to SDZNY's ROE of +0.09%. Regarding short-term risk, NPPNY is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SDZNY's competition here
NPPNY vs TEVJF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TEVJF has a market cap of 35.2B. Regarding current trading prices, NPPNY is priced at $6.66, while TEVJF trades at $30.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TEVJF's P/E ratio is 24.95. In terms of profitability, NPPNY's ROE is +0.11%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, NPPNY is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check TEVJF's competition here
NPPNY vs TAIPY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, NPPNY is priced at $6.66, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, NPPNY's ROE is +0.11%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, NPPNY is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TAIPY's competition here
NPPNY vs ESALY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, NPPNY is priced at $6.66, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ESALY's P/E ratio is 20.54. In terms of profitability, NPPNY's ROE is +0.11%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, NPPNY is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ESALY's competition here
NPPNY vs BIOVF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, BIOVF has a market cap of 16.4B. Regarding current trading prices, NPPNY is priced at $6.66, while BIOVF trades at $47.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas BIOVF's P/E ratio is 169.11. In terms of profitability, NPPNY's ROE is +0.11%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, NPPNY is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check BIOVF's competition here
NPPNY vs SGIOF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SGIOF has a market cap of 16.1B. Regarding current trading prices, NPPNY is priced at $6.66, while SGIOF trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SGIOF's P/E ratio is 14.99. In terms of profitability, NPPNY's ROE is +0.11%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, NPPNY is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SGIOF's competition here
NPPNY vs SGIOY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SGIOY has a market cap of 15.9B. Regarding current trading prices, NPPNY is priced at $6.66, while SGIOY trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SGIOY's P/E ratio is 14.80. In terms of profitability, NPPNY's ROE is +0.11%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, NPPNY is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SGIOY's competition here
NPPNY vs IPSEF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, NPPNY is priced at $6.66, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas IPSEF's P/E ratio is 18.79. In terms of profitability, NPPNY's ROE is +0.11%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, NPPNY is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check IPSEF's competition here
NPPNY vs ESALF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ESALF has a market cap of 7.9B. Regarding current trading prices, NPPNY is priced at $6.66, while ESALF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ESALF's P/E ratio is 32.56. In terms of profitability, NPPNY's ROE is +0.11%, compared to ESALF's ROE of +0.04%. Regarding short-term risk, NPPNY is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check ESALF's competition here
NPPNY vs ESAIY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ESAIY has a market cap of 7B. Regarding current trading prices, NPPNY is priced at $6.66, while ESAIY trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ESAIY's P/E ratio is 28.09. In terms of profitability, NPPNY's ROE is +0.11%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, NPPNY is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ESAIY's competition here
NPPNY vs SFOSF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, NPPNY is priced at $6.66, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, NPPNY's ROE is +0.11%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, NPPNY is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SFOSF's competition here
NPPNY vs BCHMF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, BCHMF has a market cap of 6.8B. Regarding current trading prices, NPPNY is priced at $6.66, while BCHMF trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas BCHMF's P/E ratio is 36.20. In terms of profitability, NPPNY's ROE is +0.11%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, NPPNY is more volatile compared to BCHMF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check BCHMF's competition here
NPPNY vs GZPHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, NPPNY is priced at $6.66, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, NPPNY is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check GZPHF's competition here
NPPNY vs HLUBF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HLUBF has a market cap of 5.7B. Regarding current trading prices, NPPNY is priced at $6.66, while HLUBF trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HLUBF's P/E ratio is 9.26. In terms of profitability, NPPNY's ROE is +0.11%, compared to HLUBF's ROE of +0.15%. Regarding short-term risk, NPPNY is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HLUBF's competition here
NPPNY vs HLBBF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HLBBF has a market cap of 5.2B. Regarding current trading prices, NPPNY is priced at $6.66, while HLBBF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HLBBF's P/E ratio is 12.84. In terms of profitability, NPPNY's ROE is +0.11%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, NPPNY is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HLBBF's competition here
NPPNY vs LVZPF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, NPPNY is priced at $6.66, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, NPPNY's ROE is +0.11%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, NPPNY is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check LVZPF's competition here
NPPNY vs SMDPY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SMDPY has a market cap of 4.9B. Regarding current trading prices, NPPNY is priced at $6.66, while SMDPY trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SMDPY's P/E ratio is 6.47. In terms of profitability, NPPNY's ROE is +0.11%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, NPPNY is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SMDPY's competition here
NPPNY vs DNPUF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, DNPUF has a market cap of 4.7B. Regarding current trading prices, NPPNY is priced at $6.66, while DNPUF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas DNPUF's P/E ratio is 6.21. In terms of profitability, NPPNY's ROE is +0.11%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, NPPNY is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check DNPUF's competition here
NPPNY vs LABFF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, NPPNY is priced at $6.66, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas LABFF's P/E ratio is 28.95. In terms of profitability, NPPNY's ROE is +0.11%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, NPPNY is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check LABFF's competition here
NPPNY vs SGFEF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, NPPNY is priced at $6.66, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SGFEF's P/E ratio is 20.49. In terms of profitability, NPPNY's ROE is +0.11%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, NPPNY is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SGFEF's competition here
NPPNY vs HKMPY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HKMPY has a market cap of 4.3B. Regarding current trading prices, NPPNY is priced at $6.66, while HKMPY trades at $39.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HKMPY's P/E ratio is 10.83. In terms of profitability, NPPNY's ROE is +0.11%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, NPPNY is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HKMPY's competition here
NPPNY vs HKMPF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HKMPF has a market cap of 4.3B. Regarding current trading prices, NPPNY is priced at $6.66, while HKMPF trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HKMPF's P/E ratio is 11.02. In terms of profitability, NPPNY's ROE is +0.11%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, NPPNY is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HKMPF's competition here
NPPNY vs APNHY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, APNHY has a market cap of 3.7B. Regarding current trading prices, NPPNY is priced at $6.66, while APNHY trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas APNHY's P/E ratio is -33.60. In terms of profitability, NPPNY's ROE is +0.11%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, NPPNY is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check APNHY's competition here
NPPNY vs APNHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, NPPNY is priced at $6.66, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas APNHF's P/E ratio is -32.80. In terms of profitability, NPPNY's ROE is +0.11%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, NPPNY is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check APNHF's competition here
NPPNY vs LBTSF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, NPPNY is priced at $6.66, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, NPPNY's ROE is +0.11%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, NPPNY is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check LBTSF's competition here
NPPNY vs CAMRF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, NPPNY is priced at $6.66, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CAMRF's P/E ratio is 45.08. In terms of profitability, NPPNY's ROE is +0.11%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, NPPNY is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check CAMRF's competition here
NPPNY vs HYPMY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, NPPNY is priced at $6.66, while HYPMY trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HYPMY's P/E ratio is 8.44. In terms of profitability, NPPNY's ROE is +0.11%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, NPPNY is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HYPMY's competition here
NPPNY vs INVVY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, NPPNY is priced at $6.66, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas INVVY's P/E ratio is -62.42. In terms of profitability, NPPNY's ROE is +0.11%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, NPPNY is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check INVVY's competition here
NPPNY vs DMPHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, DMPHF has a market cap of 2.9B. Regarding current trading prices, NPPNY is priced at $6.66, while DMPHF trades at $59.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas DMPHF's P/E ratio is 26.70. In terms of profitability, NPPNY's ROE is +0.11%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, NPPNY is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check DMPHF's competition here
NPPNY vs IZQVF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, NPPNY is priced at $6.66, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, NPPNY's ROE is +0.11%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, NPPNY is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check IZQVF's competition here
NPPNY vs CURLF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CURLF has a market cap of 2.6B. Regarding current trading prices, NPPNY is priced at $6.66, while CURLF trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CURLF's P/E ratio is -23.36. In terms of profitability, NPPNY's ROE is +0.11%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, NPPNY is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CURLF's competition here
NPPNY vs ULIHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, NPPNY is priced at $6.66, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, NPPNY's ROE is +0.11%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, NPPNY is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check ULIHF's competition here
NPPNY vs CHSYF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, NPPNY is priced at $6.66, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, NPPNY's ROE is +0.11%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, NPPNY is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check CHSYF's competition here
NPPNY vs NPNKF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, NPPNY is priced at $6.66, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas NPNKF's P/E ratio is 11.78. In terms of profitability, NPPNY's ROE is +0.11%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, NPPNY is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check NPNKF's competition here
NPPNY vs TSMRF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, NPPNY is priced at $6.66, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TSMRF's P/E ratio is 12.19. In terms of profitability, NPPNY's ROE is +0.11%, compared to TSMRF's ROE of +0.09%. Regarding short-term risk, NPPNY is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check TSMRF's competition here
NPPNY vs HTSUF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, NPPNY is priced at $6.66, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, NPPNY's ROE is +0.11%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, NPPNY is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HTSUF's competition here
NPPNY vs ARSUF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, NPPNY is priced at $6.66, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ARSUF's P/E ratio is 18.75. In terms of profitability, NPPNY's ROE is +0.11%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, NPPNY is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check ARSUF's competition here
NPPNY vs DUTV Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, NPPNY is priced at $6.66, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas DUTV's P/E ratio is N/A. In terms of profitability, NPPNY's ROE is +0.11%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, NPPNY is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check DUTV's competition here
NPPNY vs HMDCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HMDCF has a market cap of 1.9B. Regarding current trading prices, NPPNY is priced at $6.66, while HMDCF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HMDCF's P/E ratio is 4.08. In terms of profitability, NPPNY's ROE is +0.11%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, NPPNY is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HMDCF's competition here
NPPNY vs GTBIF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, GTBIF has a market cap of 1.7B. Regarding current trading prices, NPPNY is priced at $6.66, while GTBIF trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas GTBIF's P/E ratio is 14.43. In terms of profitability, NPPNY's ROE is +0.11%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, NPPNY is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GTBIF's competition here
NPPNY vs SHPHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, NPPNY is priced at $6.66, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, NPPNY's ROE is +0.11%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, NPPNY is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SHPHF's competition here
NPPNY vs CMOPF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CMOPF has a market cap of 1.6B. Regarding current trading prices, NPPNY is priced at $6.66, while CMOPF trades at $100.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CMOPF's P/E ratio is -387.13. In terms of profitability, NPPNY's ROE is +0.11%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, NPPNY is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CMOPF's competition here
NPPNY vs MITPF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, NPPNY is priced at $6.66, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas MITPF's P/E ratio is -10.81. In terms of profitability, NPPNY's ROE is +0.11%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, NPPNY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MITPF's competition here
NPPNY vs TCNNF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TCNNF has a market cap of 1.6B. Regarding current trading prices, NPPNY is priced at $6.66, while TCNNF trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TCNNF's P/E ratio is -20.27. In terms of profitability, NPPNY's ROE is +0.11%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, NPPNY is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TCNNF's competition here
NPPNY vs KARBF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, NPPNY is priced at $6.66, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas KARBF's P/E ratio is 262.50. In terms of profitability, NPPNY's ROE is +0.11%, compared to KARBF's ROE of N/A. Regarding short-term risk, NPPNY is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check KARBF's competition here
NPPNY vs CASBF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, NPPNY is priced at $6.66, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CASBF's P/E ratio is 198.50. In terms of profitability, NPPNY's ROE is +0.11%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, NPPNY is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CASBF's competition here
NPPNY vs CHIZF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, NPPNY is priced at $6.66, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, NPPNY's ROE is +0.11%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, NPPNY is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check CHIZF's competition here
NPPNY vs SWGHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, NPPNY is priced at $6.66, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, NPPNY's ROE is +0.11%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, NPPNY is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SWGHF's competition here
NPPNY vs KSPHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, NPPNY is priced at $6.66, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas KSPHF's P/E ratio is 14.49. In terms of profitability, NPPNY's ROE is +0.11%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, NPPNY is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check KSPHF's competition here
NPPNY vs TWAPF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, NPPNY is priced at $6.66, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, NPPNY's ROE is +0.11%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, NPPNY is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check TWAPF's competition here
NPPNY vs EVOTF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, NPPNY is priced at $6.66, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, NPPNY's ROE is +0.11%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, NPPNY is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check EVOTF's competition here
NPPNY vs LJUIF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, NPPNY is priced at $6.66, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, NPPNY's ROE is +0.11%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, NPPNY is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check LJUIF's competition here
NPPNY vs BIOGY Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, NPPNY is priced at $6.66, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, NPPNY's ROE is +0.11%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, NPPNY is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check BIOGY's competition here
NPPNY vs SHEZF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, NPPNY is priced at $6.66, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, NPPNY's ROE is +0.11%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, NPPNY is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SHEZF's competition here
NPPNY vs KKPCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, NPPNY is priced at $6.66, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, NPPNY's ROE is +0.11%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, NPPNY is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check KKPCF's competition here
NPPNY vs GNMLF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, GNMLF has a market cap of 928.9M. Regarding current trading prices, NPPNY is priced at $6.66, while GNMLF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas GNMLF's P/E ratio is 10.56. In terms of profitability, NPPNY's ROE is +0.11%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, NPPNY is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check GNMLF's competition here
NPPNY vs GLASF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, GLASF has a market cap of 847M. Regarding current trading prices, NPPNY is priced at $6.66, while GLASF trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas GLASF's P/E ratio is -16.83. In terms of profitability, NPPNY's ROE is +0.11%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, NPPNY is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GLASF's competition here
NPPNY vs CSWYF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, NPPNY is priced at $6.66, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, NPPNY's ROE is +0.11%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, NPPNY is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CSWYF's competition here
NPPNY vs TRXPF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, NPPNY is priced at $6.66, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, NPPNY's ROE is +0.11%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, NPPNY is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check TRXPF's competition here
NPPNY vs YIHCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, NPPNY is priced at $6.66, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, NPPNY is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check YIHCF's competition here
NPPNY vs AIHLF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, NPPNY is priced at $6.66, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, NPPNY's ROE is +0.11%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, NPPNY is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check AIHLF's competition here
NPPNY vs TRSSF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, NPPNY is priced at $6.66, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, NPPNY's ROE is +0.11%, compared to TRSSF's ROE of -0.75%. Regarding short-term risk, NPPNY is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TRSSF's competition here
NPPNY vs KHTRF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, KHTRF has a market cap of 589.2M. Regarding current trading prices, NPPNY is priced at $6.66, while KHTRF trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas KHTRF's P/E ratio is 150.25. In terms of profitability, NPPNY's ROE is +0.11%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, NPPNY is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check KHTRF's competition here
NPPNY vs SWDCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SWDCF has a market cap of 575.4M. Regarding current trading prices, NPPNY is priced at $6.66, while SWDCF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SWDCF's P/E ratio is 120.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, NPPNY is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SWDCF's competition here
NPPNY vs AGYTF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, NPPNY is priced at $6.66, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, NPPNY is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check AGYTF's competition here
NPPNY vs BOIRF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, NPPNY is priced at $6.66, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas BOIRF's P/E ratio is 24.17. In terms of profitability, NPPNY's ROE is +0.11%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, NPPNY is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check BOIRF's competition here
NPPNY vs PKBFF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, NPPNY is priced at $6.66, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas PKBFF's P/E ratio is N/A. In terms of profitability, NPPNY's ROE is +0.11%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, NPPNY is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check PKBFF's competition here
NPPNY vs NIKA Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, NIKA has a market cap of 534.8M. Regarding current trading prices, NPPNY is priced at $6.66, while NIKA trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas NIKA's P/E ratio is N/A. In terms of profitability, NPPNY's ROE is +0.11%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, NPPNY is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check NIKA's competition here
NPPNY vs CCHWF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, NPPNY is priced at $6.66, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, NPPNY's ROE is +0.11%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, NPPNY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CCHWF's competition here
NPPNY vs VRNOF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, NPPNY is priced at $6.66, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, NPPNY's ROE is +0.11%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, NPPNY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check VRNOF's competition here
NPPNY vs PEXXF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, NPPNY is priced at $6.66, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to PEXXF's ROE of N/A. Regarding short-term risk, NPPNY is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check PEXXF's competition here
NPPNY vs HUMDF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HUMDF has a market cap of 409.3M. Regarding current trading prices, NPPNY is priced at $6.66, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HUMDF's P/E ratio is 2.57. In terms of profitability, NPPNY's ROE is +0.11%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, NPPNY is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check HUMDF's competition here
NPPNY vs ELTP Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ELTP has a market cap of 373.4M. Regarding current trading prices, NPPNY is priced at $6.66, while ELTP trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ELTP's P/E ratio is 8.67. In terms of profitability, NPPNY's ROE is +0.11%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, NPPNY is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ELTP's competition here
NPPNY vs CRLBF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CRLBF has a market cap of 312M. Regarding current trading prices, NPPNY is priced at $6.66, while CRLBF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CRLBF's P/E ratio is -2.39. In terms of profitability, NPPNY's ROE is +0.11%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, NPPNY is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CRLBF's competition here
NPPNY vs CPHRF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CPHRF has a market cap of 300.2M. Regarding current trading prices, NPPNY is priced at $6.66, while CPHRF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CPHRF's P/E ratio is 9.98. In terms of profitability, NPPNY's ROE is +0.11%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, NPPNY is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check CPHRF's competition here
NPPNY vs GUERF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, NPPNY is priced at $6.66, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas GUERF's P/E ratio is 8.19. In terms of profitability, NPPNY's ROE is +0.11%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, NPPNY is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check GUERF's competition here
NPPNY vs BHCCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, NPPNY is priced at $6.66, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, NPPNY's ROE is +0.11%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, NPPNY is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check BHCCF's competition here
NPPNY vs PLNHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, NPPNY is priced at $6.66, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, NPPNY's ROE is +0.11%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, NPPNY is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check PLNHF's competition here
NPPNY vs CBWTF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CBWTF has a market cap of 150.7M. Regarding current trading prices, NPPNY is priced at $6.66, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CBWTF's P/E ratio is 10.74. In terms of profitability, NPPNY's ROE is +0.11%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, NPPNY is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CBWTF's competition here
NPPNY vs COPHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, NPPNY is priced at $6.66, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas COPHF's P/E ratio is -0.02. In terms of profitability, NPPNY's ROE is +0.11%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, NPPNY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check COPHF's competition here
NPPNY vs NWPN Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, NPPNY is priced at $6.66, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas NWPN's P/E ratio is -0.04. In terms of profitability, NPPNY's ROE is +0.11%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, NPPNY is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check NWPN's competition here
NPPNY vs LOVFF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, LOVFF has a market cap of 122.5M. Regarding current trading prices, NPPNY is priced at $6.66, while LOVFF trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas LOVFF's P/E ratio is 15.50. In terms of profitability, NPPNY's ROE is +0.11%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, NPPNY is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check LOVFF's competition here
NPPNY vs BIOYF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, BIOYF has a market cap of 117.3M. Regarding current trading prices, NPPNY is priced at $6.66, while BIOYF trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas BIOYF's P/E ratio is 17.89. In terms of profitability, NPPNY's ROE is +0.11%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, NPPNY is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check BIOYF's competition here
NPPNY vs LPCUF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, NPPNY is priced at $6.66, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas LPCUF's P/E ratio is 9.41. In terms of profitability, NPPNY's ROE is +0.11%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, NPPNY is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check LPCUF's competition here
NPPNY vs CNVCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, NPPNY is priced at $6.66, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, NPPNY is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check CNVCF's competition here
NPPNY vs AAWH Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, AAWH has a market cap of 108.6M. Regarding current trading prices, NPPNY is priced at $6.66, while AAWH trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas AAWH's P/E ratio is -0.84. In terms of profitability, NPPNY's ROE is +0.11%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, NPPNY is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check AAWH's competition here
NPPNY vs HLTRF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, HLTRF has a market cap of 102M. Regarding current trading prices, NPPNY is priced at $6.66, while HLTRF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas HLTRF's P/E ratio is -10.19. In terms of profitability, NPPNY's ROE is +0.11%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, NPPNY is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HLTRF's competition here
NPPNY vs ORXOF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ORXOF has a market cap of 101.9M. Regarding current trading prices, NPPNY is priced at $6.66, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ORXOF's P/E ratio is -2.27. In terms of profitability, NPPNY's ROE is +0.11%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, NPPNY is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check ORXOF's competition here
NPPNY vs GRUSF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, GRUSF has a market cap of 98.6M. Regarding current trading prices, NPPNY is priced at $6.66, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas GRUSF's P/E ratio is 39.46. In terms of profitability, NPPNY's ROE is +0.11%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, NPPNY is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GRUSF's competition here
NPPNY vs JUSHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, JUSHF has a market cap of 97M. Regarding current trading prices, NPPNY is priced at $6.66, while JUSHF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas JUSHF's P/E ratio is -1.35. In terms of profitability, NPPNY's ROE is +0.11%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, NPPNY is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check JUSHF's competition here
NPPNY vs MEDXF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, MEDXF has a market cap of 91.1M. Regarding current trading prices, NPPNY is priced at $6.66, while MEDXF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas MEDXF's P/E ratio is -141.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, NPPNY is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MEDXF's competition here
NPPNY vs SHIEF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, SHIEF has a market cap of 85.5M. Regarding current trading prices, NPPNY is priced at $6.66, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, NPPNY is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for NPPNY.Check SHIEF's competition here
NPPNY vs ABSCF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, NPPNY is priced at $6.66, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, NPPNY's ROE is +0.11%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, NPPNY is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ABSCF's competition here
NPPNY vs CWBHF Comparison May 2026
NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NPPNY stands at 1.8B. In comparison, CWBHF has a market cap of 73.9M. Regarding current trading prices, NPPNY is priced at $6.66, while CWBHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NPPNY currently has a P/E ratio of 9.65, whereas CWBHF's P/E ratio is -2.00. In terms of profitability, NPPNY's ROE is +0.11%, compared to CWBHF's ROE of -20.65%. Regarding short-term risk, NPPNY is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CWBHF's competition here